Journal of Nanobiotechnology

Young-donor cell packages better eased osteoarthritis in mice

An experiment in male mice with surgically induced disease compared packages released by human joint-lining stem cells from young and aged donors.

Paper by Zhibo Deng, Linhai Yang, Rongsheng Zhang, +9 more authorsGuoyu Yu
Figure 1 from Journal of Nanobiotechnology
Open the figure at full size
Figure 1. Deng et al., CC BY-NC-ND
Studied:
Experiments in male mice with induced osteoarthritis, against mice given aged-donor exosomes
What changed:
Walking improved more in mice given young-donor exosomes than in mice given aged-donor exosomes
The catch:
Only male mice were studied; treatment effects could differ in female mice

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

Male mice with surgically induced osteoarthritis received exosomes—tiny packages released by human joint-lining stem cells—in an animal experiment. Packages from young donors reduced cartilage damage, bony outgrowths and pain-related behavior more effectively than those from aged donors.

In injured human cartilage cells grown in the lab, young-donor packages also promoted cell growth and movement and restored mitochondrial function more effectively. Mitochondria supply cells with energy. The researchers identified miR-10a-5p, a small RNA molecule that regulates gene activity, as a candidate contributor enriched in young-donor packages. The authors concluded that this RNA suppressed a protein called CRTAC1, helping restore mitophagy—the removal of damaged mitochondria—and the balance of materials surrounding cartilage cells.

Why it matters

For osteoarthritis, an age-related joint disease, the findings offer a rationale for considering donor age and engineering RNA cargo when developing therapies based on cell-released packages.

Caveats

The joint-damage results came from male mice with surgically induced osteoarthritis. These experiments do not show whether the packages would benefit people with the disease.

Comments

Be the first to comment.